Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1Depression 1

Interventions

Radiosurgery 2Psychiatric Rehabilitation 2Vorinostat 1Uncertainty 1Therapeutics 1Temozolomide 1Radiotherapy 1Psychosocial Intervention 1Physical Examination 1Methylphenidate 1Magnetic Resonance Spectroscopy 1Duloxetine Hydrochloride 1Cognitive Behavioral Therapy 1Caregivers 1Behavior Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depression × Duloxetine Hydrochloride × CNS × Clear all
NCT02443194 2015-12-03

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Tel-Aviv Sourasky Medical Center

Phase 3 Terminated
50 enrolled
CNS

Depression, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡